Kymera Therapeutics Inc
Examining the Potential Price Growth of Kymera Therapeutics Inc (KYMR)
Kymera Therapeutics Inc’s recently made public that its Director Esposito Pamela unloaded Company’s shares for reported $2.26 million on Dec ...
Insider Sale Alert: Kymera Therapeutics Inc [KYMR] – Is it Time to sell?
Kymera Therapeutics Inc’s filing revealed that its Director Esposito Pamela unloaded Company’s shares for reported $2.26 million on Dec 17 ...
Checking in on Kymera Therapeutics Inc (KYMR) after recent insiders movement
In a filing, Kymera Therapeutics Inc revealed its Director Booth Bruce unloaded Company’s shares for reported $21.08 million on Dec ...
Kymera Therapeutics Inc [KYMR] Insider Activity: An Update for Investors
Kymera Therapeutics Inc’s filing revealed that its Director Albers Jeffrey W. unloaded Company’s shares for reported $0.45 million on Dec ...
Understanding the Risks of Investing in Kymera Therapeutics Inc (KYMR)
Kymera Therapeutics Inc’s recent filing unveils that its Chief Executive Officer Mainolfi Nello unloaded Company’s shares for reported $1.83 million ...
Understanding the Risks of Investing in Kymera Therapeutics Inc (KYMR)
Kymera Therapeutics Inc’s filing revealed that its Chief Executive Officer Mainolfi Nello unloaded Company’s shares for reported $1.83 million on ...
An Analysis of Kymera Therapeutics Inc (KYMR)’s Potential Price Growth
Kymera Therapeutics Inc’s recent filing unveils that its Chief Executive Officer Mainolfi Nello unloaded Company’s shares for reported $1.83 million ...
A Guide To The Risks Of Investing In Kymera Therapeutics Inc (KYMR)
Kymera Therapeutics Inc’s filing revealed that its Chief Executive Officer Mainolfi Nello unloaded Company’s shares for reported $1.83 million on ...
Kymera Therapeutics Inc (KYMR) receives a Buy rating from Guggenheim
Kymera Therapeutics Inc’s filing revealed that its Chief Executive Officer Mainolfi Nello unloaded Company’s shares for reported $1.83 million on ...
Kymera Therapeutics Inc [KYMR] Stock sold by Insider Gollob Jared for $3.66 million
Kymera Therapeutics Inc’s recent filing unveils that its Chief Medical Officer Gollob Jared unloaded Company’s shares for reported $3.66 million ...
